Schedule 13G ownership disclosure

Keros Therapeutics Inc

Common Stock · CUSIP: 492327101

Event date: 2026-09-30

Filing-level shares
1,813,870
Percent of class
9.1%
  • BlackRock Portfolio Management LLC

    Shares: 1,813,870 · Class: 9.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-26-001128
Form type
SCHEDULE 13G/A
Filer
BlackRock Portfolio Management LLC
CIK
CIK 2052113
Filed
Oct 27, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub